Join us for live coverage of JP Morgan Healthcare Conference, where life sciences leaders congregate in San Francisco to ...

Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

"Clinical evidence suggests that the AI technologies may improve fracture detection on X‑rays in urgent care without ...

Pharmacy numbers dropped from 11,522 in 2022 to 11,414 in 2023, and a further 436 closed this year in 2024. As numbers ...

To date, Leqembi has been approved in the US, Japan, China, South Korea, Hong Kong, Israel, UAE, GB, Mexico, and Macau, and ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

Bemdaneprocel is administered by surgical transplantation into a part of the brain known as the putamen, in the hope of ...

Each year at the JP Morgan Healthcare Conference, life sciences leaders congregate in San Francisco’s Union Square to network ...

The two companies, along with 17 US health systems, will collectively take a $320 million stake in Truveta, with Regeneron ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma ...

And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several ...